Aucta Pharmaceuticals, Inc. (AUCTA, Latin-improved, enhanced) is an emerging technology-based company focusing on the development and commercialization of Specialty Brand and Specialty Generics Products.    

Aucta is a pharmaceutical company creating better products of proven molecules using 505(b)(2) regulatory pathway.  Through innovation, Aucta is creating new therapeutics, including new dosage forms, new dosing regimens, and new indications.

Aucta has a clear therapeutic focus in CNS and Orphan indication, leveraging on its technology platforms, including pediatric, controlled release and novel delivery system. We are committed to be patient centric by continuously bringing improved forms and patient centric service platform of specialty products into the marketplace.

Aucta has operations in both New Jersey, U.S. and Shanghai, China.